A first-time-in-human randomized placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single escalating doses of the oral motilin receptor agonist GSK962040, in male and female healthy subjects.

Trial Profile

A first-time-in-human randomized placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single escalating doses of the oral motilin receptor agonist GSK962040, in male and female healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Camicinal (Primary)
  • Indications Diabetic gastroparesis; Dyspepsia
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 27 Oct 2008 Status changed from recruiting to active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top